e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Bayer Expert Forum at ERS 2014: “Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in Non-CF Bronchiectasis”
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Roundtable discussion ‘Managing
P. aeruginosa
at first isolation’
Source:
International Congress 2014 – Roundtable discussion ‘Managing
P. aeruginosa
at first isolation’
Session:
Bayer Expert Forum at ERS 2014: “Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in Non-CF Bronchiectasis”
Session type:
Evening Expert Forum
Number:
4598
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Roundtable discussion ‘Managing
P. aeruginosa
at first isolation’. International Congress 2014 – Roundtable discussion ‘Managing
P. aeruginosa
at first isolation’
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Jorge Alberto Chancafe Morgan - 22.04.2015 16:31
Excellent presentation!!!.
Jorge Alberto Chancafe Morgan - 31.03.2015 03:00
No videos are available!!!
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Roundtable discussion ‘Managing chronic
P. aeruginosa
infection’
Source: International Congress 2014 – Roundtable discussion ‘Managing chronic
P. aeruginosa
infection’
Year: 2014
Roundtable discussion ‘Managing
P. aeruginosa
exacerbations’
Source: International Congress 2014 – Roundtable discussion ‘Managing
P. aeruginosa
exacerbations’
Year: 2014
The prevalence of antimicrobial resistance of
P. aeruginosa,
K. pneumoniae, E. coli, A. baumanii
in Ukraine
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Year: 2014
Interactive case study ‘Controversies in managing
P. aeruginosa
in non-CF bronchiectasis’
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing
Pseudomonas aeruginosa
in non-CF Bronchiectasis’ – Full Video
Year: 2014
Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis- Guideline and clinical routine
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
Late Breaking Abstract - Biofilm formation by Pseudomonas aeruginosa in empyema
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Dental units as infection sources of Pseudomonas aeruginosa
Source: Eur Respir J 2008; 32: 1122-1123
Year: 2008
Risk factors for new P. aeruginosa isolation in bronchiectasis- data from the European Bronchiectasis Registry (EMBARC)
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
Pseudomonas aeruginosa
pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Macrolide resistance in
Pseudomonas aeruginosa
: implications for practice
Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017
Year: 2017
Pseudomonas aeruginosa
colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010
Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105
Year: 2006
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Source: Eur Respir J 2005; 25: 474-481
Year: 2005
Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat?
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020
Screening for methicilin-resistant staphylococcus aureus colonization: A pulmonology department experience
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept